Major Molecular Diagnostic Vendors Announce Workshops for AMP

As molecular pathologists, pharmaceutical companies and in vitro diagnostic vendors gather in Baltimore MD for the upcoming Association for Molecular Pathology (AMP) in Baltimore, MD. corporate workshops have been announced.  The workshops indicate the direction the industry is going, with new molecular technologies such as mass spec and NGS replacing traditional ones in some cases.   Roche, Abbott […]

Molecular Diagnostics Market Now Larger Than the Economies of 50 Nations, per New Report

As molecular testing vendors meet this month in Baltimore for the Association for Molecular Pathology (AMP) 2019 meeting, market research firm Kalorama Information, specialist in in vitro diagnostics markets, estimates that tests aiding the detection and treatment of disease at the molecular level are the fastest-growing test category in all diagnostics. And the firm says […]

Kalorama, Science and Medicine Group Will Be at AMP 2019

Kalorama Information, along with representatives from parent company Science and Medicine Group, will be present at the Association for Molecular Pathology (AMP) meeting in Baltimore Maryland.  We will be covering the meeting for Lab, Kalorama Information and Instrument Business Outlook. Seminars of particular interest to Kalorama Information: Practical Approaches to Centralizing (or Decentralizing) Molecular […]

IVD Procedures Reach 68 Billion

The global volume of in vitro diagnostic (IVD) procedures has reached over 68 billion and is forecast to increase 3.4% annually to 81.0 billion in 2024, according to Kalorama’s new report on procedure volumes. These statistics are important for business planning, particularly for new products. The same timeframe will see worldwide sales of IVD products […]

Qiagen/Illumina Deal: “positive development for clinical NGS”

This is a positive development for next-generation sequencing’s clinical future, not only in diagnostic assessment of disease but also in therapy selection. But this is still about future development, and we’ll watch the products that the collaboration produces. We’ll also watch what the competition does — partnerships oft beget other partnerships.” KALORAMA as quoted in […]

Six Trends You’ll Want to Know in the IVD Market

Kalorama has released its 12th Edition of The Worldwide Market for In Vitro Diagnostic Tests.  It is a complete market study of the 69+ billion-dollar industry.   Among the report’s findings are the following: Some Improvement in European IVD Markets: Kalorama found reversed austerity, LDT spending, and test innovation increased Europe market size, somewhat.  As Europe is an important market, this boosted the IVD market as a whole. New […]

IVD Market Reaches $69.2 Billion

ARLINGTON, VA., The world market for diagnostics is estimated at $69.2 billion in 2019 and is expected to grow a little more than 4% annually to reach $85.2 billion by 2024. This is according to an upcoming report by market researcher Kalorama Information, part of Science and Medicine Group. This estimate includes all laboratory and […]

New Study Predicts 1,000+ Urgent Care Centers Opening in the US Over Next Five Years

A New study from Kalorama Information said that the number of urgent care centers in the US is expected to increase from approximately 10,600 currently to more than 12,000 by 2023. The report, The Market for U.S. Urgent Care projects a growing market for the urgent care center business and a growing market for suppliers […]

AACC 2019 Anaheim: A Demand for Faster, Better, and More Relevant Tests

Kalorama Information attended the American Association of Clinical Chemistry in Anaheim this year.    We analyzed products and trends, interviewed vendors and experts, and gathered information for our 12 Edition Worldwide Market for In Vitro Diagnostics Tests report, due out this month. Time is of the essence, it is said, and that was the case […]

Our Latest Report on Next-Generation Sequencing Finds Brisk Vendor Sales, but also Users With Unaddressed Needs

The DNA sequencer market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future.  In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. It is a 4 billion […]